Worsening skin damage in patients with cutaneous lupus erythematosus may predict development of systemic lupus erythematosus - 11/01/21
Funding sources: Supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number K23AR061441. The content is solely the responsibility of the authors and does not necessarily represent the official views of the University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centers, the National Center for Research Resources, and the National Institutes of Health. |
|
Dr Walocko and Ms Black are cofirst authors. |
|
Disclosure: Dr Chong has received research grants (paid to his institution) from Biogen Inc and Daavlin Corp, is an investigator for Pfizer Inc and Biogen Inc, and has received honoraria from Viela Bio and Beacon Bioscience as a consultant. Dr Walocko, Ms Black, Mr Anderson, Dr Li, and Ms Adams-Huet have no conflicts of interest to declare. |
|
IRB approval status: Reviewed and approved by University of Texas Southwestern Medical Center IRB. |
Vol 84 - N° 2
P. 538-540 - février 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?